MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Lee, Heejeong ^a   Kim, Kyu Rae ^b   Cho, Nam Hoon ^c   Hong, Sung Ran ^d   Jeong, Hoiseon ^d   Kwon, Sun Young ^e   Park, Kwang Hwa ^f   An, Hee Jung ^g   Kim, Tae Heon ^g   Kim, Insun ^h   Yoon, Hye Kyoung ⁱ   Suh, Kwang Sun ^j   Min, Ki Ouk ^a   Choi, Hyun Joo ^a   Park, Ji Young ^k   Yoo, Chong Woo ^l   Lee, Youn Soo ^a   Lee, Hee Jin ^m   Lee, Weon Sun ^m   Park, Chul Soo ^a   Lee, Yonghee ⁿ   more..

^a The Catholic University of Korea   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Kwandong University College of Medicine   (South Korea)

^e Keimyung University   (South Korea)

^f Yonsei University Wonju   (South Korea)

^g CHA University   (South Korea)

^h Korea University College of Medicine   (South Korea)

ⁱ Inje University College of Medicine   (South Korea)

^j Chungnam National University College of Medicine   (South Korea)

^k Kyungpook National University School of Medicine   (South Korea)

^l National Cancer Center   (South Korea)

^m The Catholic University of Korea   (South Korea)

ⁿ Ajou University School of Medicine   (South Korea)

more..

Author keywords

MicroRNA; Minimal deviation adenocarcinoma; Notch; Uterine cervix

Indexed keywords

FORMALDEHYDE; MICRORNA; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PARAFFIN; PROTEIN MIR 135A 3P; PROTEIN MIR 136 3P; PROTEIN MIR 192 5P; PROTEIN MIR 194 5P; PROTEIN MIR 204 5P; PROTEIN MIR 299 5P; PROTEIN MIR 34B 5P; PROTEIN MIR 424 5P; PROTEIN MIR 494; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; NOTCH1 PROTEIN, HUMAN; NOTCH2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; UTERINE CERVIX CARCINOMA; ADENOCARCINOMA; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SECONDARY; SURVIVAL RATE; UTERINE CERVIX; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; CASE-CONTROL STUDIES; CERVIX UTERI; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; ROC CURVE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84922726697     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-334     Document Type: Article

References (45)

1. Kurman RJ, Ellenson LH, Ronnett BM: Carcinoma and other tumors of the cervix. In Blaustein's Pathology of the Female Genital Tract. 6th edition. Edited by Kurman RJ, Ellenson LH, Ronnett BM. New York: Springer-Verlag; 2011:280-282.
2. Tsuda H, Mikami Y, Kaku T, Akiyama F, Hasegawa T, Okada S, Hayashi I, Kasamatsu T: Interobserver variation in the diagnosis of adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. Pathol Int 2003, 53:440-449.
3. Ishii K, Hosaka N, Toki T, Momose M, Hidaka E, Tsuchiya S, Katsuyama T: A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch 1998, 432:315-322.
4. Mikami Y, Kiyokawa T, Hata S, Fujiwara K, Moriya T, Sasano H, Manabe T, Akahira J, Ito K, Tase T, Yaegashi N, Sato I, Tateno H, Naganuma H: Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod Pathol 2004, 17:962-972.
5. Mikami Y, McCluggage WG: Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions. Adv Anat Pathol 2013, 20:227-237.
6. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, Richart RM, Isacson C: Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000, 157:1055-1062.
7. An HJ, Kim KR, Kim IS, Kim DW, Park MH, Park IA, Suh KS, Seo EJ, Sung SH, Sohn JH, Yoon HK, Chang ED, Cho HI, Han JY, Hong SR, Ahn GH: Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 2005, 18:528-534.
8. Hart WR: Symposium part II: special types of adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2002, 21:327-346.
9. Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE: Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989, 13:717-729.
10. Kaku T, Enjoji M: Extremely well-differentiated adenocarcinoma ("adenoma malignum") of the cervix. Int J Gynecol Pathol 1983, 2:28-41.
11. Kaminski PF, Norris HJ: Minimal deviation carcinoma (adenoma malignum) of the cervix. Int J Gynecol Pathol 1983, 2:141-152.
12. Silverberg SG, Hurt WG: Minimal deviation adenocarcinoma ("adenoma malignum") of the cervix: a reappraisal. Am J Obstet Gynecol 1975, 121:971-975.
13. Lim KT, Lee IH, Kim TJ, Kwon YS, Jeong JG, Shin SJ: Adenoma malignum of the uterine cervix: clinicopathologic analysis of 18 cases. Kaohsiung J Med Sci 2012, 28:161-164.
14. Zhang W, Dahlberg JE, Tam W: MicroRNAs in tumorigenesis: a primer. Am J Pathol 2007, 171:728-738.
15. Kumar V, Abbas A, Fausto N, Aster J: Genetic disorders. In Robbins and Cotran Pathologic Basis of Disease. 8th edition. Edited by Schmitt W. Philadelphia: Saunders Elsevier; 2010:137.
16. Slack FJ, Weidhaas JB: MicroRNA in cancer prognosis. N Engl J Med 2008, 359:2720-2722.
17. Hede K: Small RNAs are raising big expectations. J Natl Cancer Inst 2009, 101:840-841.
18. Lee H, Choi HJ, Kang CS, Lee HJ, Lee WS, Park CS: Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma. Mod Pathol 2012, 25:1508-1515.
19. Deng S, Calin GA, Croce CM, Coukos G, Zhang L: Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008, 7:2643-2646.
20. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE: The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009, 112:55-59.
21. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJ, Yang PC: MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13:48-57.
22. Zheng ZM, Wang X: Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta 2011, 1809:668-677.
23. Pereira PM, Marques JP, Soares AR, Carreto L, Santos MA: MicroRNA expression variability in human cervical tissues. PLoS One 2010, 5:e11780.
24. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS: Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 2008, 14:2535-2542.
25. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008, 3:e2557.
26. Lui WO, Pourmand N, Patterson BK, Fire A: Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007, 67:6031-6043.
27. Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, Lu W, Wan X, Ma D, Xie X: Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 2011, 224:484-495.
28. Witten D, Tibshirani R, Gu SG, Fire A, Lui WO: Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 2010, 8:58.
29. Rao Q, Shen Q, Zhou H, Peng Y, Li J, Lin Z: Aberrant microRNA expression in human cervical carcinomas. Med Oncol 2012, 29:1242-1248.
30. Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE, Kiviat NB: Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One 2011, 6:e28423.
31. Baldi A, De Falco M, De Luca L, Cottone G, Paggi MG, Nickoloff BJ, Miele L, De Luca A: Characterization of tissue specific expression of Notch-1 in human tissues. Biol Cell 2004, 96:303-311.
32. Heinze G, Schemper M: A solution to the problem of separation in logistic regression. Stat Med 2002, 21:2409-2419.
33. Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, Kim G, An HJ: Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology 2010, 57:734-743.
34. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
35. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103:2257-2261.
36. Kang H, An HJ, Song JY, Kim TH, Heo JH, Ahn DH, Kim G: Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression. Histopathology 2012, 61:576-586.
37. Sakamoto K, Fujii T, Kawachi H, Miki Y, Omura K, Morita K, Kayamori K, Katsube K, Yamaguchi A: Reduction of NOTCH1 expression pertains to maturation abnormalities of keratinocytes in squamous neoplasms. Lab Invest 2012, 92:688-702.
38. Veeraraghavalu K, Pett M, Kumar RV, Nair P, Rangarajan A, Stanley MA, Krishna S: Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J Virol 2004, 78:8687-8700.
39. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S: Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A 1995, 92:6414-6418.
40. Maliekal TT, Bajaj J, Giri V, Subramanyam D, Krishna S: The role of Notch signaling in human cervical cancer: implications for solid tumors. Oncogene 2008, 27:5110-5114.
41. Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, Shen Y, Lu W, Wan X, Xie X: miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 2011, 179:2580-2588.
42. Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X: A microRNA expression signature for cervical cancer prognosis. Cancer Res 2010, 70:1441-1448.
43. Wang L, Wang Q, Li HL, Han LY: Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma-relationship with prognosis. Asian Pac J Cancer Prev 2013, 14:2113-2118.
44. Luo M, Shen D, Zhou X, Chen X, Wang W: MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery 2013, 153:836-847.
45. Shen SN, Wang LF, Jia YF, Hao YQ, Zhang L, Wang H: Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn Pathol 2013, 8:69.